23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.

23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

Direct to Consumer Test and Ancestry Testing - March 14, 2023

Bloomberg Businessweek NOV 8, 2021 The Spit-Tube Startup wants to be a big-time

FDA Clears 23AndMe's DTC Breast Cancer Gene Test -- But 'Buyer Beware

23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

Allowing 23andMe To Test For BRCA May Do More Harm Than Good

Drugmakers plan to pay $20M for DNA from 23andMe customers

Drugmakers are set to pay 23andMe millions to access consumer DNA

23andMe vs. China's 23Mofang Review: What Do DNA Tests Tell You? - Bloomberg

23andMe Is Really a Biotech Firm, Analyst Says - Barron's

The 23andMe Incident Highlights Genetic Privacy Limits